-
21.发明公开
公开(公告)号：EP4383395A1
公开(公告)日：2024-06-12
申请号：EP23215089.6
申请日：2023-12-07
申请人： SK On Co., Ltd.
发明人： PARK, Min Woo , KIM, Jeong Yun , PARK, Seon Yeong
IPC分类号： H01M10/0567 , H01M10/0569
CPC分类号： H01M10/0567 , H01M10/0569 , H01M10/0568 , H01M4/5825 , H01M10/0525
摘要： An electrolyte for a lithium secondary battery according to an embodiment of the present disclosure includes, a non-aqueous organic solvent including a propionate solvent; and a lithium salt. The propionate solvent includes at least one of ethyl propionate (EP) and propyl propionate (PP). The lithium salt includes lithium hexafluorophosphate (LiPF6) and lithium bisfluorosulfonylimide (LiFSI).
-
22.发明公开
公开(公告)号：EP4379854A1
公开(公告)日：2024-06-05
申请号：EP23213559.0
申请日：2023-11-30
发明人： KANG, Min Suk , KIL, Hyo Shik , DO, Ji Yae , BEAK, Min Cheol
IPC分类号： H01M4/136 , H01M4/58 , H01M4/36 , H01M10/052 , H01M4/02
CPC分类号： H01M4/5825 , H01M2004/02820130101 , H01M4/136 , H01M4/366 , H01M10/052
摘要： Cathode active materials for lithium secondary batteries and lithium secondary batteries including the cathode active materials are disclosed. In an embodiment, a cathode active material includes a lithium iron phosphate-based particle including a surface portion and a central portion, both of which includes vanadium (V). A total weight of the vanadium contained in the lithium iron phosphate-based particle includes a first weight amount of vanadium contained in the surface portion of the lithium iron phosphate-based particle and a second weight amount of vanadium contained in the central portion of the lithium iron phosphate-based particle, and the first weight amount is greater than the second weight amount.
-
23.发明公开
公开(公告)号：EP4379053A2
公开(公告)日：2024-06-05
申请号：EP24156927.6
申请日：2019-10-09
发明人： KULKARNI, Jayesh , HILL, Austin , CULLIS, Pieter , LEAVITT, Blair , PETKAU, Terri , WAGNER, Pamela
IPC分类号： C12N15/11
CPC分类号： A61P25/28 , A61P25/16 , C12N15/113 , C12N15/88 , C12N2310/2020170501 , C12N15/111 , C12N2310/1420130101 , A61K9/1272 , A61K9/0019
摘要： Lipid-based vesicles, typically herein called transfection competent vesicles (TCVs), configured to safely and efficiently deliver DNA, RNA, other nucleic acid and protein cargoes into target cells. The safety and efficiency are each, and both, achieved in part by eliminating organic solvents such as ethanol and detergents such as sodium dodecyl sulfate from the TCV loading processes (i.e., inserting a cargo into the TCV), TCV storage processes, and/or TCV delivery processes. The cargoes can also comprise nucleic acids complexed with a protein, such as a ribonucleoprotein (RNP). The systems, compositions, devices and methods, etc., herein, in some embodiments, can provide empty TCVs that can if desired be loaded at the bench without use of specialized equipment.
-
公开(公告)号：EP4327886A3
公开(公告)日：2024-05-22
申请号：EP23201319.3
申请日：2012-08-23
申请人： Libertas Bio, Inc.
发明人： Venkatesan, Aranapakam , Smith, Roger Astbury , Hosahalli, Subramanya , Potluri, Vijay , Panigrahi, Sunil Kumar , Basetti, Vishnu , Kuntu, Karunasree
IPC分类号： C07D487/04 , C07D519/00 , A61K31/519 , A61P29/00
CPC分类号： A61K31/519 , C07D487/04 , C07D519/00 , A61P11/06 , A61P17/00 , A61P19/02 , A61P19/08 , A61P25/00 , A61P25/28 , A61P29/00 , A61P3/00 , A61P35/00 , A61P37/00 , A61P37/06 , A61P37/08 , A61P43/00 , A61P5/00 , A61P9/00
摘要： The present application provides novel pyrimido-pyridazinone compounds and methods for using these compounds. These compounds are useful in treating inflammation in patients by administering one or more of the compounds to a patient. In one embodiment, the novel pyrimido-pyridazinone compound is of Formula (I) and R1 and R2 are defined herein.
-
公开(公告)号：EP3890035B1
公开(公告)日：2024-05-22
申请号：EP21171313.6
申请日：2009-06-16
IPC分类号： H01L33/50 , H01L25/075 , F21Y115/10 , F21Y113/13 , F21V23/00 , F21K9/00
-
26.发明公开
公开(公告)号：EP4364722A1
公开(公告)日：2024-05-08
申请号：EP22864985.1
申请日：2022-08-29
发明人： PARK, Sang Han , KANG, Bok Ki , KIM, Dong Hwan , KANG, Min Hyeong
IPC分类号： A61K9/00 , A61K9/08 , A61K9/107 , A61K31/7042 , A61K31/7034 , A61K31/7048 , A61P27/02
CPC分类号： A61K9/107 , A61K9/00 , A61K31/7048 , A61K31/7034 , A61P27/02 , A61K31/7042 , A61K9/08
摘要： The present invention relates to a pharmaceutical composition for preventing or treating diabetic eye disease, comprising sodium-glucose cotransporter-2 (SGLT-2) inhibitor, and a method for preventing or treating diabetic eye disease by using same.
-
公开(公告)号：EP4360887A1
公开(公告)日：2024-05-01
申请号：EP22828005.3
申请日：2022-03-24
申请人： SIJTechnology, Inc.
发明人： MURATA Kazuhiro
摘要： A nozzle head includes a plate portion arranged in a plate shape, a droplet discharging nozzle portion located in the plate portion, the droplet discharging nozzle portion including a plurality of droplet discharging nozzles ejecting droplets by an electrostatic discharging method, and a pseudo-nozzle portion located around the droplet discharging nozzle portion in the plate portion and including a plurality of pseudo-nozzles. In the nozzle head described above, the plurality of droplet discharging nozzles may be arranged in line in a first direction, and the pseudo-nozzle portion may be arranged on both sides of the droplet discharging nozzle portion.
-
公开(公告)号：EP4053945B1
公开(公告)日：2024-05-01
申请号：EP22156654.0
申请日：2022-02-14
CPC分类号： H01M4/505 , H01M4/525 , H01M10/0525 , H01M2004/02120130101 , H01M4/131 , H01M4/366
-
公开(公告)号：EP3964546B1
公开(公告)日：2024-05-01
申请号：EP20798391.7
申请日：2020-04-09
CPC分类号： C08L61/06 , F16D69/00 , F16D65/092 , F16D2069/00720130101 , F16D65/0006 , F16D69/026 , F16D2200/008620130101
-
公开(公告)号：EP3640232B1
公开(公告)日：2024-04-24
申请号：EP18818798.3
申请日：2018-05-14
-
-
-
-
-
-
-
-
-
搜索结果
1727 条记录 (耗时 0.028 秒)
